Zimmer Holdings, Inc., formerly Zodiac Holdings, Inc., is engaged in the design, development, manufacturing and marketing of orthopedic reconstructive implants and fracture management products. Orthopedic reconstructive implants restore joint function lost due to disease or trauma in joints such as knees, hips, shoulders and elbows. Fracture management products are devices used primarily to reattach or stabilize damaged bone and tissue to support the body's natural healing process. The Company also manufactures and markets other products relating to orthopedic and general surgery. The Company has operations in approximately 20 countries and markets its products in approximately 70 countries, with the United States accounting for the highest percentage of its sales. Zimmer Holdings was spun-off from Bristol-Myers Squibb on August 7, 2001.